APA način citiranja

Rubin, D. T., Cohen, R. D., Sandborn, W. J., Lichtenstein, G. R., Axler, J., Riddell, R. H., . . . Forbes, W. P. (2017). Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial. J Crohns Colitis.

Čikaški stil citiranja

Rubin, David T., et al. "Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial." J Crohns Colitis 2017.

MLA način citiranja

Rubin, David T., et al. "Corrigendum: Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial." J Crohns Colitis 2017.